🔎 Trials Near Me

Beranda › Sarkoma Ewing › Distrik Columbia

Uji klinis Sarkoma Ewing di Distrik Columbia

6 studi untuk Sarkoma Ewing mencari peserta di lokasi di Distrik Columbia.

Kota di Distrik Columbia

Teks studi resmi (Bahasa Inggris)

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's National Medical Center, Washington D.C.
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Menerima pesertaFase 1
Usia 1 hingga 23 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT07172958

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

  • Sibley Memorial Hospital, Washington D.C.
Menerima peserta
Hingga usia 39 · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT06796543

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's National Medical Center, Washington D.C.
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT04901702

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's National Hospital, Washington D.C.
Menerima pesertaFase 1/2
Usia 2 hingga 30 · Semua jenis kelamin · Diperbarui 3 Feb 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's National Medical Center, Washington D.C.
Menerima pesertaFase 2
18 Months – 40 Years · Semua jenis kelamin · Diperbarui 12 Agu 2025 · NCT05135975

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.